...: Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-983 4. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirinsensitive patients. Br Med J 1975;1:67-69...

.... Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-983 4. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirinsensitive patients. Br Med J 1975;1:67-69 5. Settipane GA...

... and nonsteroidal anti-inflammatory drugs. Ann Allergy 1993;71:417-418. 8. Stevenson DD, Sánchez-Borges M, Szczeklik A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177-180. 9. Kowalski ML, Makowska JS, Blanca M...

...References References 1. Widal F, Abrami P, Lermoyez J: Anaphylaxie et idiosyncrasie. 1992 [anaphylaxis and idiosyncrasy. 1992]. Allergy Proc 1993;14:373-376; discussion 371-372. 2. Stevenson DD, Sanchez-Borges M, Szczeklik A: Classification of allergic and pseudoallergic reactions...

... found to be common in aspirin-induced angioedema and urticaria [ 12 ]. This observation led Szczeklik [ 13 ] to propose the cyclooxygenase theory. Overproduction of cysteinyl leukotrienes, increased expression of CysLTR1 in the airways mucosa [ 14 ], decreased production of prostaglandin E 2 , which...

... P, Lermoyez J: Anaphylaxie et idiosyncrasie. 1992 [anaphylaxis and idiosyncrasy. 1992]. Allergy Proc 1993;14:373-376; discussion 371-372. 2. Stevenson DD, Sanchez-Borges M, Szczeklik A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann...

...: Adverse-drug-reaction monitoring. N Engl J Med 1986;314:1589-1592 13. Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913-921quiz 922. 14. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik...

... 2000;13:29-33. 24. Swierczynska M, Nizankowska-Mogilnicka E, Zarychta J, Gielicz A, Szczeklik A: Nasal versus bronchial and nasal response to oral aspirin challenge: clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. J Allergy Clin Immunol 2003;112:995-1001...

... and other betalactams. Curr Pharm Des 2006;12:3327-3333 6. Blanca M, Romano A, Torres MJ, Demoly P, DeWeck A: Continued need of appropriate betalactam-derived skin test reagents for the management of allergy to betalactams. Clin Exp Allergy 2007;37:166-173 7. Szczeklik A, Nizankowska-Mogilnicka E...

... Halpern, Jacques Charpin, Lino Businco, Jacques Pepys, W.J. Quarles van Ufford, Andrzej Szczeklik, Z. Eriksson-Lihr, A.D. Ado. Who would you list among the top 10 living allergists? A. William Frankland, Gunnar Johansson, Alain de Weck 1 , Kimishige Ishizaka, Stephen Holgate, Barry Kay, Estelle...

... K, Nizankowska E, Szczeklik A: A controlled study of 9alpha, 11beta-PGF 2 (a prostaglandin D. metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol 2003;111:(4)743-9 5. Dahlen SE, Kumlin M: Monitoring mast cell...

.... Dahlen B, Nizankowska E, Szczeklik A, et al: Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998;157(4 pt 1):1187-1194. ...

..., Nizankowska-Mogilnicka E, Zarychta J, Gielicz A, Szczeklik A: Nasal versus bronchial and nasal response to oral aspirin challenge: clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. J Allergy Clin Immunol 2003;112:995-1001. 25. Corrigan C, Mallett K, Ying S, et al...

... alCytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006;355:1018-1028 12. Faich GA: Adverse-drug-reaction monitoring. N Engl J Med 1986;314:1589-1592 13. Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management...

... M, Romano A, Torres MJ, Demoly P, DeWeck A: Continued need of appropriate betalactam-derived skin test reagents for the management of allergy to betalactams. Clin Exp Allergy 2007;37:166-173 7. Szczeklik A, Nizankowska-Mogilnicka E, Sanak M: Hypersensitivity to aspirin and other NSAIDs...

... and lipoxins - new potential performers in the regulation of human myelopoiesis. Leuk Res 1994;18:727-732 93. Sanak M, Levy BD, Clish CB, Chiang N, Gronert K, Mastalerz L, Serhan CN, Szczeklik A: Aspirintolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 2000;16:44...

... after aspirin. Clin Immunol 1996;98:(2)421-32 4. Bochenek G, Nagraba K, Nizankowska E, Szczeklik A: A controlled study of 9alpha, 11beta-PGF 2 (a prostaglandin D. metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol...